Vienna-based precision fermentation company Fermify has submitted a regulatory dossier for its animal-free casein to the Singapore Food Agency (SFA). The submission represents a step toward commercializing its dairy protein alternative in the Asian market.
“We are very proud to be the first who have submitted a regulatory dossier for animal-free casein in Asia”
The company, which focuses on sustainable dairy production without the use of animals, previously submitted its casein dossier to the US Food and Drug Administration (FDA) in October 2024, where it achieved self-affirmed Generally Recognized as Safe (GRAS) status.
Fermify’s casein, produced through precision fermentation, is designed to replicate the functional properties of traditional dairy proteins, enabling the production of cheese that melts and stretches without requiring milk from cows. The company emphasizes its product as a solution to the environmental and ethical concerns associated with conventional dairy.
Eva Sommer, CEO and founder of Fermify explains, “Singapore is a global leader in food tech regulation and a gateway to the Asian market. This submission is a key step toward bringing our technology to consumers and food manufacturers. Our precision fermentation platform unlocks the potential for sustainable dairy production without compromising on taste, texture, or functionality.”
Singapore’s role in alt-protein innovation
The Singapore Food Agency is responsible for regulating food safety and approving novel food products in the country. In recent years, Singapore has positioned itself as a hub for alternative proteins, having approved several cultivated meat and precision-fermented dairy products.
Fermify announced the submission on LinkedIn, stating, “Regulatory barriers are one of the biggest hurdles for precision fermentation, and we are very proud to be the first who have submitted a regulatory dossier for animal-free casein in Asia.”
